Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Osteocalcin-positive Cells as a Cell-Based Biomarker of Breast Cancer Bone Metastasis Progression

NCT03814811 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03814811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03814811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Osteocalcin-positive Cells as a Cell-Based Biomarker of Breast Cancer Bone Metastasis Progression
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2017
Completion date
December 31, 2021
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, breast neoplasms